Search Results
Search results for "Dongbo Bu"
Results found for "Dongbo Bu"
- Jane Lamerdin and Gaurav Agrawal: Building GPCR Assays That Reflect Real Biology | Dr. GPCR Ecosystem
. << Back to podcast list Strategic Partner(s) Jane Lamerdin and Gaurav Agrawal: Building GPCR Assays In this conversation, two Eurofins DiscoverX scientists reflect on what nearly three decades of building Lamerdin and Agrawal explain why the field, and increasingly regulators, now expect assays built closer Failure is documented, not buried. The support inbox and community collaborations feed directly back into what gets built next.
- Silvio Gutkind: Building a Lab That Doesn't Shut Down | Dr. GPCR Ecosystem
. << Back to podcast list Strategic Partner(s) Silvio Gutkind: Building a Lab That Doesn't Shut Down Gutkind — carrying a personal loss in New York and leading a cancer center building that operated at He walks through the structure his team built: staggered schedules at 10–15% occupancy, written contracts Gutkind a pre-built mental model for what to freeze, what to protect, and what to let continue. The contract wasn't bureaucracy; it was protection, especially for students.
- About Dr. GPCR Podcast | Dr. GPCR Ecosystem
We also know that you are busy, which is why we designed this short survey that should take you 5 minutes
- GPCR Webinars | Dr. GPCR Ecosystem
is doing about it, and the challenge it comes with: A high-throughput recombinant antibody platform built Built for the GPCR community, by the GPCR community. Trial → University Premium 👉 Sign Up for Notifications These sessions are part of a larger mission: building Whether you're deep in receptor biology or evaluating assay tools, these sessions are built for you.
- David Gloriam: Orphan Receptors, GPCRDB, and the Data Revolution in GPCR Pharmacology | Dr. GPCR Ecosystem
Until that pathway-level map is built, designing genuinely biased drugs remains a hypothesis in search The result was a structured group management model built around four specialized subgroups, each with
- Recombinant Antibodies for GPCRs: A Challenge to the Community | Dr. GPCR Ecosystem
Inside the platform The production workflow is built to detect promising clones early and to hold specificity Ball will walk through how the recombinant platform was built, what it takes to produce specific antibodies The company's GPCR program is building a comprehensive catalog of recombinant monoclonal antibodies for
- Dr. Terry Hebert: A Pharmacologist Thinking Through Lockdown | Dr. GPCR Ecosystem
the shutdown, including a newly accepted BRET-based platform for beta-1 adrenergic receptor signaling built Hebert, the conversation is also about what he had to let go of: the assumption that a lab, once built The beta-1 adrenergic receptor paper — a BRET-based platform for capturing downstream signaling, built
- Xylazine, Fentanyl, and the Fight for Breath with Catherine Demery | Dr. GPCR Ecosystem
designing preclinical models of fentanyl and xylazine overdose, she reflects on staying in academia, building What You’ll Learn in This Episode How industry lab experience builds the discipline needed for academic
- Team Access to Terry’s Pharmacology Corner | 25% Group Discount | Dr. GPCR Ecosystem
Activation typically takes 3–10 business days . Need to add members later? Explore : Foundational Lessons — Build Your Pharmacology Core Emerging Drug Hunter — Expand Your Edge
- Aaron Sato: Synthetic Antibody Libraries for the Hardest GPCR Targets | Dr. GPCR Ecosystem
Aaron Sato on building the synthetic antibody library that finally makes GPCRs tractable — and the greenfield This conversation explores how synthetic antibody phage display libraries, built on silicon-based DNA For Aaron, this work is personal: he has built his career hunting greenfield targets where others had His current focus is building synthetic phage display libraries that drug targets the field has long
- Robert J. Lefkowitz: Beta-Adrenergic Receptors, the GPCR Family, and Fifty Years of Discovery | Dr. GPCR Ecosystem
And I remember thinking to myself as a young buck at the time: I'm going to show this guy.
- Anita Nivedha: Computational Dynamics of Ligand Bias in GPCR Signaling | Dr. GPCR Ecosystem
led him into GPCR research, drug discovery, and membrane protein biology—plus practical insights on building
- Eleonora Comeo: Fluorescent Ligands and the Pharmacology of Adenosine Receptors | Dr. GPCR Ecosystem
For Comeo, who entered GPCR research without any background in the field and built her PhD around chemistry
- Our History | Dr. GPCR Ecosystem
Oct 2021 — Featured at ERNEST with Where All GPCRs Are Created Equal . 2022 Building Momentum Podcast
- Eurofins Discovery GPCR Solutions | Drug Discovery & Development Partner | Dr. GPCR
View Signature Panels Purpose-built GPCR panels Run in agonist formats for profiling, selectivity, and
- Who We Are | Dr. GPCR Ecosystem
We’re building together, with input from across the field. About Dr. News See Why it Matters 6,600+ followers 200+ Research Labs 1,500+ Scientists 50+ Biotech Companies Built What We Believe The Ecosystem was built with five key beliefs: Scientific rigor first This is a space Transparency builds trust We're open about who we are and what we do. We built Dr.
- Dr. GPCR Ecosystem
Built for founders who prefer clarity over chaos and confusion. Biotech Decision Vault by Attila Foris Strategic Business & Operating Systems Advisor Dr.
- GPCR CRO Bank | Dr. GPCR Ecosystem
We are building the world's first CRO Service-focused GPCR bank. Build Trust Develop content that speaks their language and establishes your credibility in the GPCR research Built for discovery and evaluation These channels are used to support discovery and evaluation — helping
- GPCR University Group Package | Dr. GPCR Ecosystem
Activation typically takes 3–10 business days . Need to add members later?
- Sri Kosuri | Dr. GPCR Ecosystem
Sri Kosuri Sri is a biologist that has helped build technologies, labs, and companies in synthetic biology His lab has worked on building large-scale ways of empirically exploring questions in protein biochemistry Sri previously worked at the Wyss Institute and Harvard, where he built numerous technologies in gene He helped build Gen9, a gene synthesis company, as a member of the SAB and was the first employee of
- Join the Dr. GPCR Affiliate Program - Empower the GPCR Community with Dr. GPCR Ecosystem Services
Become our Brand Ambassador Our vision is to build the best platform for the GPCR community and help you the scientists and business owners to share their experiences with others, get help, and find the perfect tools, colleagues, build their strategy and advance our field. blogging, guest blogging, - Podcast, video, vlog - Social media sharing, - YouTube & TikTok channels, - Business It will be a remarkable journey and fun to build together the "next-generation" platform for the B2B
- Yamina's Corner | Dr. GPCR Ecosystem
Streamline workflows and improve scientific execution to increase client satisfaction and secure repeat business ensuring every strategic decision efficiently propels your program forward and aligns with critical business Core Values: The Foundation of Every Successful Partnership My advisory is built on principles that ensure Whether it's optimizing CRO selection, building robust internal capabilities, or translating complex
- Dr. Andrew Tobin | Dr. GPCR Ecosystem
Research Centre (ARC) a collaborative initiative at the University of Glasgow underpinned by a £118M new build
- Paul Insel: Rethinking COVID-19 Pathobiology Through GPCR Signaling | Dr. GPCR Ecosystem
off-label drug use during a pandemic Key Insights from the Conversation The ACE inhibitor scare was built Nature has built in these systems consistently." — Dr.
- Alexander Hauser: GPCR Pharmacogenomics and Precision Psychiatry | Dr. GPCR Ecosystem
relationships after departure 37:19 - Networking, collaboration, and the danger of doing science in a bubble 44:18 - Building toward an independent group - precision psychiatry as the research anchor 46:06 - The
- Donate to Dr GPCR — Support the GPCR Community & University
Dr GPCR is a 501(c)(3) non-profit. 501(c)(3) Non-Profit Help Us Build a Global Home for GPCR Science
- Brian Arey - Part 2: GPCR Drug Discovery and the Science Nobody Publishes | Dr. GPCR Ecosystem
Target validation programs are built, defended, and sometimes cancelled before a single paper is submitted to enter fields - bone biology, thrombosis, endothelial function - with limited prior expertise and build Scientists who build careers in this space often generate more foundational knowledge than their publication The discipline requires a willingness to invest in an outcome that might close what you have built. KLF2-GPCR axis in atherosclerosis: a program that ended, a conviction that did not Arey spent years building
- Pfleger: NanoBRET, Receptor Complexes, and the Translation of GPCR Pharmacology | Dr. GPCR Ecosystem
The development of NanoBRET - including live-cell ligand binding assays built on CRISPR-expressed receptors The PhD Trains You for Far More Than the Bench The skills built during doctoral training - managing time It is a transferable toolkit most PhD students do not realize they have built. It's so many other things - whether it's about time management, people management, managing a budget. These are all business skills. And these are all skills that can be transferred."
- Dr. Josephine (Pina) Cardarelli | Dr. GPCR Ecosystem
Burixafor, their most advanced clinical candidate, will be in Phase II clinical trial next year.
- Chris Tate: Thermostabilizing GPCRs for Structural Biology | Dr. GPCR Ecosystem
thermostability of diacylglycerol kinase - a protein with no connection to GPCRs - produced a light-bulb


















